Explain the term "myelosuppression."

Study for the ONS/ONCC Chemotherapy Immunotherapy CAQ Renewal Test. Test with flashcards and multiple choice questions, each question has hints and explanations. Get ready for your exam!

Myelosuppression refers to a decrease in the activity of the bone marrow, which is the site of blood cell production. This condition results in a significant reduction in the manufacturing of red blood cells, white blood cells, and platelets. The implications of myelosuppression are critical; for example, a decrease in red blood cells can lead to anemia, reduced white blood cells can increase the risk of infection, and a drop in platelets can result in bleeding and bruising.

Understanding myelosuppression is particularly important in the context of chemotherapy and certain other treatments, as these therapies can directly impact bone marrow function, leading to this condition. This condition is not isolated to a specific form of treatment, and it can be a general side effect of various treatments, including chemotherapy, certain medications, and even some forms of radiation therapy tailored toward treating cancers.

In contrast, the other options highlight conditions or effects that do not align with the definition of myelosuppression. Increased white blood cell counts typically suggest an immune response or infection being fought, rather than a suppression of blood cell production. An immune response to cancer cells illustrates a body reaction to disease rather than a condition of reduced blood cell production. Finally, while myelosuppression can

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy